Atlas Trials

Study Evaluating Bifeprunox in Bipolar Depression

Clinical trial NCT00245973 · COMPLETED

Trial details

NCT number
NCT00245973
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Depression Bipolar
Start date
2005-06-01
Enrollment
380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.